Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E)

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Zarrouk, Amira ^a,b   Vejux, Anne ^a   Nury, Thomas ^a   El Hajj, Hammam I ^a   Haddad, Madouda ^a   Cherkaoui Malki, Mustapha ^a   Riedinger, Jean Marc ^c   Hammami, Mohamed ^b   Lizard, Gérard ^a  

^a Faculté des Sciences Gabriel   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c Centre de Lutte Contre le Cancer GF Leclerc   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER PATIENTS; ALZHEIMER'S DISEASE; CELL COUNTING; LIPID ALTERATION; MITOCHONDRIAL COMPLEX; MITOCHONDRIAL DYSFUNCTION; MTT ASSAYS; NEURODEGENERATION; NEURONAL CELL; NEURONAL DAMAGE; POTENTIAL RISKS; SUPEROXIDE ANIONS; TRANSMEMBRANE POTENTIALS; VERY LONG-CHAIN FATTY ACIDS; WESTERN BLOTTING; WHOLE CELL;

BIOELECTRIC POTENTIALS; CYTOLOGY; NEURONS; OXYGEN; TRANSMISSION ELECTRON MICROSCOPY;

MITOCHONDRIA;

VERY LONG CHAIN FATTY ACID; FATTY ACID; MULTIPROTEIN COMPLEX; SUPEROXIDE;

ARTICLE; CELL COUNT; CELL GROWTH; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MORPHOLOGY; NERVE CELL; NERVE DEGENERATION; OXIDATIVE STRESS; TOPOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; CELL PROLIFERATION; CELL SHAPE; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEIN SUBUNIT; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; FATTY ACIDS; FLOW CYTOMETRY; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MULTIPROTEIN COMPLEXES; NEURONS; OXIDATIVE STRESS; PROTEIN SUBUNITS; SUPEROXIDES;

EID: 84866159844     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/623257     Document Type: Article

References (74)

1. Burns A., Iliffe S., Alzheimer's disease. British Medical Journal 2009 338, article b158 2-s2.0-60849134017
2. Querfurth H. W., LaFerla F. M., Alzheimer's disease. The New England Journal of Medicine 2010 362 4 329 344 2-s2.0-75449102536 10.1056/NEJMra0909142
3. Hardy J., A hundred years of Alzheimer's disease research. Neuron 2006 52 1 3 13 2-s2.0-33749177143 10.1016/j.neuron.2006.09.016 (Pubitemid 44472602)
4. O'Brien R. J., Wong P. C., Amyloid precursor protein processing and Alzheimer's disease. Annual Review of Neuroscience 2011 34 185 204 2-s2.0-79959886270 10.1146/annurev-neuro-061010-113613
5. Hooper C., Killick R., Lovestone S., The GSK3 hypothesis of Alzheimer's disease. Journal of Neurochemistry 2008 104 6 1433 1439 2-s2.0-39849110726 10.1111/j.1471-4159.2007.05194.x (Pubitemid 351316776)
6. Hernández F., Gómez de Barreda E., Fuster-Matanzo A., Lucas J. J., Avila J., GSK3: a possible link between beta amyloid peptide and tau protein. Experimental Neurology 2010 223 2 322 325 2-s2.0-77952546195 10.1016/j.expneurol.2009.09.011
7. Hartmann T., Kuchenbecker J., Grimm M. O., Alzheimer's disease: the lipid connection. Journal of Neurochemistry 2007 103 159 170 2-s2.0-38449115897 10.1111/j.1471-4159.2007.04715.x
8. Grösgen S., Grimm M. O. W., Frie P., Hartmann T., Role of amyloid beta in lipid homeostasis. Biochimica et Biophysica Acta 2010 1801 8 966 974 2-s2.0-77953279456 10.1016/j.bbalip.2010.05.002
9. Hayashi H., Lipid metabolism and glial lipoproteins in the central nervous system. Biological and Pharmaceutical Bulletin 2011 34 4 453 461 2-s2.0-79953769393 10.1248/bpb.34.453
10. Seripa D., D'Onofrio G., Panza F., Cascavilla L., Masullo C., Pilotto A., The genetics of the human APOE polymorphism. Rejuvenation Research 2011 14 5 491 500 10.1089/rej.2011.1169
11. Bekris L. M., Yu C. E., Bird T. D., Tsuang D. W., Review article: genetics of Alzheimer disease. Journal of Geriatric Psychiatry and Neurology 2010 23 4 213 227 2-s2.0-78649232442 10.1177/0891988710383571
12. Javitt N. B., Oxysterols: novel biologic roles for the 21st century. Steroids 2008 73 2 149 157 2-s2.0-37649021073 10.1016/j.steroids.2007.10.004
13. Leoni V., Caccia C., Oxysterols as biomarkers in neurodegenerative diseases. Chemistry and Physics of Lipids 2011 164 6 515 524 2-s2.0-80051472136 10.1016/j.chemphyslip.2011.04.002
14. Russell D. W., Oxysterol biosynthetic enzymes. Biochimica et Biophysica Acta 2000 1529 13 126 135 2-s2.0-0034672672 10.1016/S1388-1981(00)00142-6
15. Schroepfer G. J. Jr., Oxysterols: modulators of cholesterol metabolism and other processes. Physiological Reviews 2000 80 1 361 554 2-s2.0-0342316532 (Pubitemid 30060568)
16. Vejux A., Lizard G., Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Molecular Aspects of Medicine 2009 30 3 153 170 2-s2.0-67349159434 10.1016/j.mam.2009.02.006
17. Nelson T. J., Alkon D. L., Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. Biochemical Society Transactions 2005 33 5 1033 1036 2-s2.0-27844458139 10.1042/BST20051033 (Pubitemid 41659107)
18. Vaya J., Schipper H. M., Oxysterols, cholesterol homeostasis, and Alzheimer disease. Journal of Neurochemistry 2007 102 6 1727 1737 2-s2.0-34548231638 10.1111/j.1471-4159.2007.04689.x (Pubitemid 47329280)
19. Solomon A., Leoni V., Kivipelto M., Besga A., Öksengård A. R., Julin P., Svensson L., Wahlund L. O., Andreasen N., Winblad B., Soininen H., Björkhem I., Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neuroscience Letters 2009 462 1 89 93 2-s2.0-67650432608 10.1016/j.neulet.2009.06.073
20. Russell D. W., Halford R. W., Ramirez D. M. O., Shah R., Kotti T., Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annual Review of Biochemistry 2009 78 1017 1040 2-s2.0-67650751079 10.1146/annurev.biochem.78.072407.103859
21. Brown J. III, Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J. M., Yager D., Crowley J., Sambamurti K., Rahman M. M., Reiss A. B., Eckman C. B., Wolozin B., Differential expression of cholesterol hydroxylases in Alzheimer's disease. The Journal of Biological Chemistry 2004 279 33 34674 34681 2-s2.0-4544255297 10.1074/jbc.M402324200 (Pubitemid 39318097)
22. Prasanthi J. R. P., Huls A., Thomasson S., Thompson A., Schommer E., Ghribi O., Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on β -amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Molecular Neurodegeneration 2009 4 1, article 1 2-s2.0-62149140601 10.1186/1750-1326-4-1
23. Björkhem I., Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. Journal of Internal Medicine 2006 260 6 493 508 2-s2.0-33751096969 10.1111/j.1365-2796.2006.01725.x (Pubitemid 44772369)
24. Björkhem I., Cedazo-Minguez A., Leoni V., Meaney S., Oxysterols and neurodegenerative diseases. Molecular Aspects of Medicine 2009 30 3 171 179 2-s2.0-67349094556 10.1016/j.mam.2009.02.001
25. Terlecky S. R., Koepke J. I., Walton P. A., Peroxisomes and aging. Biochimica et Biophysica Acta 2006 1763 12 1749 1754 2-s2.0-33845289270 10.1016/j.bbamcr.2006.08.017 (Pubitemid 44880468)
26. Titorenko V. I., Terlecky S. R., Peroxisome metabolism and cellular aging. Traffic 2011 12 3 252 259 2-s2.0-79751472085 10.1111/j.1600-0854.2010. 01144.x
27. Santos M. J., Quintanilla R. A., Toro A., Grandy R., Dinamarca M. C., Godoy J. A., Inestrosa N. C., Peroxisomal proliferation protects from β -amyloid neurodegeneration. The Journal of Biological Chemistry 2005 280 49 41057 41068 2-s2.0-28844467909 10.1074/jbc.M505160200 (Pubitemid 41780601)
28. Cimini A., Moreno S., D'Amelio M., Cristiano L., D'Angelo B., Falone S., Benedetti E., Carrara P., Fanelli F., Cecconi F., Amicarelli F., Cerù M. P., Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. Journal of Alzheimer's Disease 2009 18 4 935 952 2-s2.0-74949133060 10.3233/JAD-2009- 1199
29. Wanders R. J. A., Waterham H. R., Biochemistry of mammalian peroxisomes revisited. Annual Review of Biochemistry 2006 75 295 332 2-s2.0-33746366462 10.1146/annurev.biochem.74.082803.133329 (Pubitemid 44118035)
30. Lizard G., Rouaud O., Demarquoy J., Cherkaoui-Malki M., Iuliano L., Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. Journal of Alzheimer's disease 2012 29 2 241 254
31. Kou J., Kovacs G. G., Höftberger R., Kulik W., Brodde A., Forss-Petter S., Hönigschnabl S., Gleiss A., Brügger B., Wanders R., Just W., Budka H., Jungwirth S., Fischer P., Berger J., Peroxisomal alterations in Alzheimer's disease. Acta Neuropathologica 2011 122 3 271 283 2-s2.0-79955967756 10.1007/s00401-011-0836-9
32. Eichler F. S., Ren J. Q., Cossoy M., Rietsch A. M., Nagpal S., Moser A. B., Frosch M. P., Ransohoff R. M., Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Annals of Neurology 2008 63 6 729 742 2-s2.0-46749133930 10.1002/ana.21391 (Pubitemid 351945532)
33. Hein S., Schönfeld P., Kahlert S., Reiser G., Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Human Molecular Genetics 2008 17 12 1750 1761 2-s2.0-44849118490 10.1093/hmg/ddn066 (Pubitemid 351791501)
34. Baarine M., Ragot K., Athias A., Nury T., Kattan Z., Genin E. C., Andreoletti P., Ménétrier F., Riedinger J. M., Bardou M., Lizard G., Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF- α on oligodendrocytes and astrocytes. Neurotoxicology 2012 33 2 212 228 10.1016/j.neuro.2011.10.007
35. Baarine M., Andréoletti P., Athias A., Nury T., Zarrouk A., Ragot K., Vejux A., Riedinger J.-M., Kattan Z., Bessede G., Trompier D., Savary S., Cherkaoui-Malki M., Lizard G., Evidence of oxidative stress in very long chain fatty acidtreated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience 2012 213 1 18 2-s2.0-84861658605 10.1016/j.neuroscience.2012.03.058
36. Dumont M., Beal M. F., Neuroprotective strategies involving ROS in Alzheimer disease. Free Radical Biology and Medicine 2011 51 5 1014 1026 2-s2.0-78650546948 10.1016/j.freeradbiomed.2010.11.026
37. Swerdlow R. H., Brain aging, Alzheimer's disease, and mitochondria. Biochimica et Biophysica Acta 2011 1812 12 1630 1639 10.1016/j.bbadis.2011.08. 012
38. Lezi E., Swerdlow R. H., Mitochondria in neurodegeneration. Advances in Experimental Medicine and Biology 2012 942 2 269 286 10.1007/978-94-007-2869-112
39. Singh I., Kishimoto Y., Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds. Journal of Lipid Research 1983 24 5 662 665 2-s2.0-0020559784 (Pubitemid 13059199)
40. Takemoto Y., Suzuki Y., Horibe R., Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain and Development 2003 25 7 481 487 10.1016/S0387-7604(03)00033-0 (Pubitemid 37485654)
41. Lizard G., Gueldry S., Deckert V., Gambert P., Lagrost L., Evaluation of the cytotoxic effects of some oxysterols and of cholesterol on endothelial cell growth: methodological aspects. Pathologie Biologie 1997 45 4 281 290 2-s2.0-0030925092 (Pubitemid 27260566)
42. Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983 65 1-2 55 63 2-s2.0-0021061819 (Pubitemid 14203433)
43. Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., Corcos L., Gambert P., Néel D., Lizard G., Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biology and Toxicology 2005 21 2 97 114 2-s2.0-24344434230 10.1007/s10565-005-0141-2 (Pubitemid 41253203)
44. Rothe G., Valet G., Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′7′- dichlorofluorescin. Journal of Leukocyte Biology 1990 47 5 440 448 2-s2.0-0025218905 (Pubitemid 20155877)
45. Haugland R. P., Molecular Probes Handbook, a Guide to Fluorescent Probes and Labeling Technologies 2010 11th Molecular Probes, Invitrogen, Life Technologies. edited by I. Johnson and M. T. Z. Spence
46. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C., Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985 150 1 76 85 10.1016/0003-2697(85)90442-7 (Pubitemid 16258399)
47. Lizard G., Fournel S., Genestier L., Dhedin N., Chaput C., Flacher M., Mutin M., Panaye G., Revillard J. P., Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995 21 3 275 283 2-s2.0-0028875851 10.1002/cyto.990210308
48. Kahn E., Baarine M., Dauphin A., Ragot K., Tissot N., Seguin A., Ménétrier F., Kattan Z., Bachelet C. M., Frouin F., Lizard G., Impact of 7-ketocholesterol and very long chain fatty acids on oligodendrocyte lipid membrane organization: evaluation via LAURDAN and FAMIS spectral image analysis. Cytometry A 2011 79 4 293 305 2-s2.0-79953016042 10.1002/cyto.a.21017
49. Marshall N. J., Goodwin C. J., Holt S. J., A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regulation 1995 5 2 69 84 2-s2.0-0029076753
50. Lizard G., Deckert V., Dubrez L., Moisant M., Gambert P., Lagrost L., Induction of apoptosis in endothelial cells treated with cholesterol oxides. American Journal of Pathology 1996 148 5 1625 1638 2-s2.0-0029960080 (Pubitemid 26135902)
51. Lenaz G., D'Aurelio M., Merlo Pich M., Genova M. L., Ventura B., Bovina C., Formiggini G., Parenti Castelli G., Mitochondrial bioenergetics in aging. Biochimica et Biophysica Acta 2000 1459 2-3 397 404 2-s2.0-0034663641 10.1016/S0005-2728(00)00177-8 (Pubitemid 30612413)
52. Navarro A., Boveris A., Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease. Frontiers in Aging Neuroscience 2010 2, article 34
53. Zahm J. M., Baconnais S., Monier S., Bonnet N., Bessède G., Gambert P., Puchelle E., Lizard G., Chronology of cellular alterations during 7-ketocholesterol-induced cell death on A7R5 rat smooth muscle cells: analysis by time lapse-video microscopy and conventional fluorescence microscopy. Cytometry A 2003 52 2 57 69 2-s2.0-0346244108 (Pubitemid 37521504)
54. Cottet-Rousselle C., Ronot X., Leverve X., Mayol J. F., Cytometric assessment of mitochondria using fluorescent probes. Cytometry A 2011 79 6 405 425 2-s2.0-79956153476 10.1002/cyto.a.21061
55. Fourcade S., López-Erauskin J., Galino J., Duval C., Naudi A., Jove M., Kemp S., Villarroya F., Ferrer I., Pamplona R., Portero-Otin M., Pujol A., Early oxidative damage underlying neurodegeneration in X- adrenoleukodystrophy. Human Molecular Genetics 2008 17 12 1762 1773 2-s2.0-44849100253 10.1093/hmg/ddn085 (Pubitemid 351791502)
56. Galea E., Launay N., Portero-Otin M., Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochimica et Biophysica Acta 2012 1822 9 1475 1488 10.1016/j.bbadis.2012.02.005
57. Vargas C. R., Wajner M., Sirtori L. R., Goulart L., Chiochetta M., Coelho D., Latini A., Llesuy S., Bello-Klein A., Giugliani R., Deon M., Mello C. F., Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochimica et Biophysica Acta 2004 1688 1 26 32 2-s2.0-12144288732 10.1016/j.bbadis.2003.10.004 (Pubitemid 38366303)
58. Deon M., Sitta A., Barschak A. G., Coelho D. M., Terroso T., Schmitt G. O., Wanderley H. Y. C., Jardim L. B., Giugliani R., Wajner M., Vargas C. R., Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy. Journal of the Neurological Sciences 2008 266 1-2 79 83 2-s2.0-38749140623 10.1016/j.jns.2007.08.043 (Pubitemid 351186525)
59. Deon M., Sitta A., Barschak A. G., Coelho D. M., Pigatto M., Schmitt G. O., Jardim L. B., Giugliani R., Wajner M., Vargas C. R., Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. International Journal of Developmental Neuroscience 2007 25 7 441 444 2-s2.0-36049050412 10.1016/j.ijdevneu.2007.08.008 (Pubitemid 350086846)
60. Galino J., Ruiz M., Fourcade S., Schlüter A., López-Erauskin J., Guilera C., Jove M., Naudi A., García-Arumí E., Andreu A. L., Starkov A. A., Pamplona R., Ferrer I., Portero-Otin M., Pujol A., Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 2011 15 8 2095 2107 10.1089/ars.2010.3877
61. Nulton-Persson A. C., Szweda L. I., Modulation of mitochondrial function by hydrogen peroxide. The Journal of Biological Chemistry 2001 276 26 23357 23361 2-s2.0-0035968183 10.1074/jbc.M100320200
62. Fourcade S., Ruiz M., Guilera C., Hahnen E., Brichta L., Naudi A., Portero-Otín M., Dacremont G., Cartier N., Wanders R., Kemp S., Mandel J. L., Wirth B., Pamplona R., Aubourg P., Pujol A., Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Human Molecular Genetics 2010 19 10 2005 2014 2-s2.0-77952508899 10.1093/hmg/ddq082
63. Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., Mandel J. L., Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Human Molecular Genetics 2002 11 5 499 505 2-s2.0-0036501313 (Pubitemid 34257486)
64. Uto T., Contreras M. A., Gilg A. G., Singh I., Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Developmental Neuroscience 2009 30 6 410 418 2-s2.0-58749085411 10.1159/000191212
65. Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pàmpols T., Giròs M., Mandel J. L., Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Human Molecular Genetics 2004 13 23 2997 3006 2-s2.0-9744221106 10.1093/hmg/ddh323 (Pubitemid 39585232)
66. Breuer M. E., Koopman W. J., Koene S., Nooteboom M., Rodenburg R. J., Willems P. H., Smeitink J. A., The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases. Neurobiology of Disease. In press 10.1016/j.nbd.2012.03.007
67. Dirkx R., Vanhorebeek I., Martens K., Schad A., Grabenbauer M., Fahimi D., Declercq P., van Veldhoven P. P., Baes M., Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology 2005 41 4 868 878 2-s2.0-16244397057 10.1002/hep.20628 (Pubitemid 40462950)
68. Baumgart E., Vanhorebeek I., Grabenbauer M., Borgers M., Declercq P. E., Fahimi H. D., Baes M., Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). American Journal of Pathology 2001 159 4 1477 1494 2-s2.0-0034799180 (Pubitemid 32947977)
69. Chowanadisai W., Bauerly K. A., Tchaparian E., Wong A., Cortopassi G. A., Rucker R. B., Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1 α expression. The Journal of Biological Chemistry 2010 285 1 142 152 2-s2.0-73649125823 10.1074/jbc.M109.030130
70. Tornatore T. F., Dalla Costa A. P., Clemente C. F. M. Z., Judice C., Rocco S. A., Calegari V. C., Cardoso L., Cardoso A. C., Gonçalves A. Jr., Franchini K. G., A role for focal adhesion kinase in cardiac mitochondrial biogenesis induced by mechanical stress. American Journal of Physiology 2011 300 3 H902 H912 2-s2.0-79955067768 10.1152/ajpheart.00319.2010
71. Chang D. T. W., Reynolds I. J., Mitochondrial trafficking and morphology in healthy and injured neurons. Progress in Neurobiology 2006 80 5 241 268 2-s2.0-33845927357 10.1016/j.pneurobio.2006.09.003 (Pubitemid 46028946)
72. Ahuja P., Zhao P., Angelis E., Ruan H., Korge P., Olson A., Wang Y., Jin E. S., Jeffrey F. M., Portman M., MacLellan W. R., Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. Journal of Clinical Investigation 2010 120 5 1494 1505 2-s2.0-77951839683 10.1172/JCI38331
73. Jeng J. Y., Lee W. H., Tsai Y. H., Chen C. Y., Chao S. Y., Hsieh R. H., Functional modulation of mitochondria by eicosapentaenoic acid provides protection against ceramide toxicity to C6 glioma cells. Journal of Agricultural and Food Chemistry 2009 57 24 11455 11462 2-s2.0-73349131068 10.1021/jf902021h
74. Reddy P. H., Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectrums 2009 14 8, supplement 7 8 13 2-s2.0-73349132395